🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
This study aims to evaluate alternative dosing regimens of single-agent bel...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-03-03
Trial ID
NCT05064358
Treatments Being Tested
This is a research study to find out if a drug called belantamab mafodotin ...
Status
Not Yet Recruiting
Location
Johnston Hematology and Oncology of Clayton
Start Date
2026-05
Trial ID
NCT05874193
Treatments Being Tested
This phase II trial investigates the effect of belantamab mafodotin and len...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2024-08-19
Trial ID
NCT04876248
Treatments Being Tested
This phase II trial tests alternate doses and dosing schedules of belantama...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2024-01-04
Trial ID
NCT05847569
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
Doctors leading this study hope to learn if the combination of belantamab m...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2023-05-30
Trial ID
NCT05789303
Treatments Being Tested
This phase II trial studies the effect of belantamab mafodotin, pomalidomid...
Status
Recruiting
Location
Emory University/Winship Cancer Institute
Start Date
2022-07-21
Trial ID
NCT05208307
Treatments Being Tested
The purpose of this umbrella study is to evaluate isatuximab when combined ...
Status
Recruiting
Location
Winship Cancer Institute of Emory University- Site Number : 8400010
Start Date
2021-01-25
Trial ID
NCT04643002
The purpose of this study is to describe the real-world use of Belantamab M...
Status
Completed
Location
Duke University Medical Center
Start Date
2023-09-18
Trial ID
NCT05986682
Treatments Being Tested